122 related articles for article (PubMed ID: 16044447)
1. Successful treatment of intestinal hemorrhage in a Jehovah's Witness patient.
Veneri D; Franchini M
Am J Hematol; 2005 Aug; 79(4):344-5. PubMed ID: 16044447
[No Abstract] [Full Text] [Related]
2. Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia.
Virchis A; Hughes C; Berney S
Hematol J; 2004; 5(3):281-2. PubMed ID: 15167918
[No Abstract] [Full Text] [Related]
3. Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa?
Ballen J; Raabe M; Muirhead B
Can J Anaesth; 2006 Apr; 53(4):353-6. PubMed ID: 16575032
[TBL] [Abstract][Full Text] [Related]
4. Use of recombinant activated factor VII in a Jehovah's Witness patient.
Hsieh A; Cheong I
Am J Emerg Med; 2007 Nov; 25(9):1085.e1-2. PubMed ID: 18022514
[No Abstract] [Full Text] [Related]
5. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven).
Tanaka KA; Waly AA; Cooper WA; Levy JH
Anesthesiology; 2003 Jun; 98(6):1513-5. PubMed ID: 12766668
[No Abstract] [Full Text] [Related]
6. A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature.
Haan J; Scalea T
Am Surg; 2005 May; 71(5):414-5. PubMed ID: 15986972
[TBL] [Abstract][Full Text] [Related]
7. Prevention and treatment of major blood loss.
Detry O; De Roover A; Honoré P
N Engl J Med; 2007 Sep; 357(12):1261; author reply 1261. PubMed ID: 17891839
[No Abstract] [Full Text] [Related]
8. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period.
Tanchev S; Platikanov V; Karadimov D
Acta Obstet Gynecol Scand; 2005 Apr; 84(4):402-3. PubMed ID: 15762974
[No Abstract] [Full Text] [Related]
9. Postpartum hemorrhage in a Jehovah's Witness patient controlled with Tisseel, tranexamic acid, and recombinant factor VIIa.
Arab TS; Al-Wazzan AB; Maslow K
J Obstet Gynaecol Can; 2010 Oct; 32(10):984-7. PubMed ID: 21176309
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated factor VII for a warfarinised Jehovah's Witness with an acute subdural haematoma.
Goldberg R; Drummond KJ
J Clin Neurosci; 2008 Oct; 15(10):1164-6. PubMed ID: 17702584
[TBL] [Abstract][Full Text] [Related]
11. Recombinant factor VIIa for major obstetric haemorrhage in a Jehovah's Witness.
Laird R; Carabine U
Int J Obstet Anesth; 2008 Apr; 17(2):193-4. PubMed ID: 18308545
[No Abstract] [Full Text] [Related]
12. Recombinant factor VIIa in massive postpartum haemorrhage.
Karalapillai D; Popham P
Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
[TBL] [Abstract][Full Text] [Related]
13. Mortality risk stratification in severely anaemic Jehovah's Witness patients.
Beliaev AM; Marshall RJ; Smith W; Windsor JA
Intern Med J; 2012 Mar; 42(3):e1-3. PubMed ID: 22432994
[TBL] [Abstract][Full Text] [Related]
14. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa.
Mindikoglu AL; Anantharaju A; George M; Leone N; Bejna J; Van Thiel DH
Hepatogastroenterology; 2003; 50(53):1697-9. PubMed ID: 14571820
[TBL] [Abstract][Full Text] [Related]
15. Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding.
Mantzios G; Tsirigotis P; Pappa V; Spirou K; Giannopoulou V; Kaitsa I; Girkas K; Papageorgiou E; Dervenoulas J
Eur J Haematol; 2007 Feb; 78(2):173-4. PubMed ID: 17313564
[No Abstract] [Full Text] [Related]
16. The use of recombinant factor viia in a jehovah's witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage.
Waddington DP; McAuley FT; Hanley JP; Summerfield GP
Br J Haematol; 2002 Oct; 119(1):286-8. PubMed ID: 12358947
[No Abstract] [Full Text] [Related]
17. A 44-year-old Jehovah's Witness with life-threatening anemia from uterine bleeding.
Hashem B; Dillard TA
Chest; 2004 Mar; 125(3):1151-4. PubMed ID: 15006982
[No Abstract] [Full Text] [Related]
18. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
Tofil NM; Winkler MK; Watts RG; Noonan J
Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
[TBL] [Abstract][Full Text] [Related]
19. Administration of four-factor prothrombin complex concentrate for a life-threatening bleed in a Jehovah's Witness patient.
Cole JL; McLeod ND
Blood Coagul Fibrinolysis; 2018 Jan; 29(1):120-122. PubMed ID: 28938310
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy-associated breast cancer: a review for the obstetrical care provider.
Somerset D
J Obstet Gynaecol Can; 2011 Sep; 33(9):897-898. PubMed ID: 21923985
[No Abstract] [Full Text] [Related]
[Next] [New Search]
